Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
原能生物（上海原能细胞生物低温设备有限公司） positions itself as a provider of integrated solutions for intelligent cell and biological sample biobanks. Its core offering is not a standalone SaaS product, but a one-stop solution that combines cryogenic storage equipment, automated transfer equipment, laboratory automation devices, consumables, and biobank management software. It serves use cases across medical institutions, biopharmaceutical companies, research institutes, public health, and related fields.
Based on the site content, its products cover two major temperature ranges: -196°C deep cryogenic liquid nitrogen storage and -80°C ultra-low-temperature storage. It also offers multiple equipment formats, including honeycomb-style, C-shaped structures, fully automated systems, and fully enclosed systems. Supporting capabilities include AGV sample transfer robots, RGV rail robots, lightweight rail systems, pass-through windows, tube-picking and liquid-handling workstations, controlled-rate freezing, cell thawing, environmental monitoring, and barcode scanning devices. On the software side, it provides an intelligent biobank management system, a sample information management system (Biobank), and a 5G-IoT remote management platform, supporting needs such as sample retrieval, traceability, and remote management.
The website does not disclose standard packages, subscription pricing, or free trial information. It appears to be more oriented toward project-based procurement and customized implementation. For deployment, the site only mentions options such as the OBS-Cyber standalone version, Plus network version, Pro biobank management version, and the 5G-IoT platform. It does not clearly specify public cloud SaaS, private deployment, APIs, or developer documentation.
Its strengths lie in its high degree of software-hardware integration, covering the full workflow of sample preparation, cooling, transfer, storage and retrieval, management, and operations and maintenance. The company also discloses 600+ domestic and international patents, 500+ granted patents, 70+ software copyrights, and multiple hospital, laboratory, and CDC-related case studies. The drawbacks are the lack of key enterprise software details: permission systems, third-party integrations, data encryption, audit logs, compliance certifications, after-sales SLAs, and pricing are all not clearly stated.
It is suitable for organizations building medium-to-large biobanks, cell banks, disease control sample repositories, or research sample resource libraries, especially projects that require unattended operation, automated storage and retrieval, and long-term low-temperature preservation. As the official website of a Chinese company, it should be directly accessible from mainland China.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on bio-bank.com official site.
bio-bank.com is an China Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach bio-bank.com directly.